Skip to Content

Forfivo XL Approval History

FDA Approved: Yes (First approved November 10, 2011)
Brand name: Forfivo XL
Generic name: bupropion hydrochloride
Dosage form: Extended Release Tablets
Company: IntelGenx Corp.
Treatment for: Depression, Major Depressive Disorder

Forfivo XL (bupropion) is a high-strength formulation of the aminoketone antidepressant bupropion (contained in Wellbutrin) indicated for the treatment of major depressive disorder.

Development History and FDA Approval Process for Forfivo XL

DateArticle
Nov 11, 2011Approval IntelGenx Announces FDA Approval of its High Dose Anti-Depressant Forfivo XL

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide